Cara Therapeutics Inc. logo

Cara Therapeutics Inc. (69C)

Market Closed
17 Jul, 20:00
XFRA XFRA
2. 06
+0.06
+3%
- Market Cap
- P/E Ratio
- Div Yield
177 Volume
-2.04 Eps
2
Previous Close
Add Transaction
Day Range
2.06 2.06
Year Range
0.99 37
Want to track 69C and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Name Time Cons. EPS Eps
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
11 Mar 2026
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
12 May 2025
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
3 Mar 2025
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
11 Nov 2024
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
5 Aug 2024
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
4 Jun 2024
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
13 May 2024
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
4 Mar 2024
-
-
Cara Therapeutics Inc. logo
69C Cara Therapeutics Inc.
13 Nov 2023
-
-

69C Earnings Reports FAQ

What is the earnings per share (EPS) for 69C?

The current EPS is -2.04.

What is the company's earnings growth rate?

Cara Therapeutics Inc has not announced its next earnings release date. You can monitor upcoming announcements in Marketlog's earnings calendar or in the company profile.

When is the next earnings release date?

Cara Therapeutics Inc has not announced its next earnings release date.

What were the most recent quarterly earnings?

The most recent quarterly earnings for Cara Therapeutics Inc are not available at this time.

What is the price-to-earnings (P/E) ratio?

There is no P/E ratio for 69C at this time, as Cara Therapeutics Inc has no recent EPS data to calculate it.